Evidence map›Paper›PMID 34212767›Full record

ArticleJournal of the American Heart Association2021

Can't Patch Everything: Personalized Medicine for Cell Therapy in Dilated Cardiomyopathy.

Andrew Sundin, Wayne Balkan, Joshua M Hare

Open access · goldAbstract readEditorialComment
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew SundinInterdisciplinary Stem Cell Institute University of Miami Miller School of Medicine Miami FL.
Wayne BalkanInterdisciplinary Stem Cell Institute University of Miami Miller School of Medicine Miami FL.
Joshua M HareInterdisciplinary Stem Cell Institute University of Miami Miller School of Medicine Miami FL.
University of Miami · US

Funding

Cardioprotective Effect of Growth Hormone Releasing HormoneR01HL107110 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2011 to 2020
$5.9M
Mesenchymal stem cell therapy for endothelial dysfunction in diabetesR01HL134558 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2016 to 2020
$3.2M
Nitric Oxide and sex differences in cardiac repairR01HL137355 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2017 to 2020
$1.6M
NHLBI NIH HHS R01 HL107110NHLBI NIH HHS R01 HL134558NHLBI NIH HHS R01 HL137355
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiomyopathy, DilatedCell- and Tissue-Based TherapyHumansPrecision MedicineStroke VolumeVentricular Function, Leftcardiac remodelingcell transplantationEditorialsgeneticsnonischemic cardiomyopathyregeneration

Identifiers

PMID34212767
PMCPMC8403302
OpenAlexW3173646917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.